Fluoroquinolones may reduce the risk of myocardial infarction

Antibiotic treatment for infections of Chlamydia pneumoniae has been associated with protection against myocardial infarction, probably via a stabilizing effect on the cytoskeleton of endothelial cells and on chondrocytes in humans. Dr Herings et al from the Netherlands decided to test this association through a case-control study to see whether patients receiving antibiotics for Chlamydia pneumoniae infections were less likely to have been admitted for a first acute MI (JAMA 2000 284:2998-2999)

By | January 3, 2001

Antibiotic treatment for infections of Chlamydia pneumoniae has been associated with protection against myocardial infarction, probably via a stabilizing effect on the cytoskeleton of endothelial cells and on chondrocytes in humans. Dr Herings et al from the Netherlands decided to test this association through a case-control study to see whether patients receiving antibiotics for Chlamydia pneumoniae infections were less likely to have been admitted for a first acute MI (JAMA 2000 284:2998-2999).

They identified 628 patients, aged 35 to 75, admitted with a first hospitalization for MI, studied their drug history, and compared them to 1615 matched controls. Only intake of high doses of fluoroquinolones was significantly associated with a lower risk of acute myocardial infarction. For those who took more than one course of fluoroquinolones, the odds ratio was 0.12 (95% CI, 0.02-0.94). For all other antibiotics, in particular tetracyclines and macrolides, no significant association was observed.

The authors hypothesize the negative association of fluoroquinolones with MI may be mediated via their nonbacterial inhibitory actions, which may prevent calcification in the later stages of plaque formation.

Popular Now

  1. Thousands of Mutations Accumulate in the Human Brain Over a Lifetime
  2. Two Dozen House Republicans Do an About-Face on Tuition Tax
  3. 2017 Top 10 Innovations
    Features 2017 Top 10 Innovations

    From single-cell analysis to whole-genome sequencing, this year’s best new products shine on many levels.

  4. The Biggest DNA Origami Structures Yet
    Daily News The Biggest DNA Origami Structures Yet

    Three new strategies for using DNA to generate large, self-assembling shapes create everything from a nanoscale teddy bear to a nanoscale Mona Lisa.

FreeShip